The Scientist profiles Aaron Chiechanover, who shared the 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation ― a determination he made as part of his PhD thesis. “We didn’t set out to identify ubiquitin. We didn’t know anything about ubiquitin or its function,” Ciechanover tellsThe Scientist. “We were studying intracellular proteolysis and we bumped into it.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.